In addition, inflammageing and subclinical inflammation, particularly in the context of obesity, share mechanisms such as the TLR pathways, NF-κB pathway, NLRP3 inflammasome activation, oxidative stress, mitochondrial dysfunction, immune cell population alterations, and gut microbiome changes. The gene discussed is NLRP3; the disease is obesity disorder.